Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

Friday’s trading has closed, but NBIX is being traded in the after-hours session. After-Hours quote »
48.55
Delayed Data
As of 3:59pm ET
 +0.46 / +0.96%
Today’s Change
15.10
Today|||52-Week Range
56.18
+117.32%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close48.09
Today’s open47.47
Day’s range47.18 - 49.16
Volume680,418
Average volume (3 months)855,471
Market cap$4.1B
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)-4.53%
Earnings growth (next 5 years)-9.18%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book17.62

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.33-1.06%
ACADACADIA Pharmaceutica...+0.33+0.84%
AKRXAkorn Inc-0.08-0.21%
RAREUltragenyx Pharmaceu...+0.04+0.03%
Data as of 3:59pm ET, 09/04/2015

Financials

Next reporting dateNovember 2, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$0.00
Annual profit (last year)-$60.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts

Partner Offers